European Cardiology Review (ECR)  is an international, English language, peer-reviewed journal that is indexed on PubMed, Scopus and the Emerging Sources Citation Index (ESCI). It comprises balanced and comprehensive original research, review articles, editorials and case reports written by leading authorities, addressing the most important and salient developments in cardiovascular medicine and practice.

Led by Editor-in-Chief Juan Carlos Kaski, along with Associate Editor Pablo Avanzas and an editorial board of world-renowned physicians, the journal publishes peer-reviewed articles that aim to provide timely updates on the most pertinent issues in the field.

For information on submitting an article, please contact the Managing Editor: Ashlynne Merrifield: ashlynne.merrifield@radcliffe-group.com or submit directly here.

     

What is the Real Message of the ISCHEMIA Trial from a Clinician’s Perspective?

Author : Islam Y Elgendy, Carl J Pepine

Citation :

European Cardiology Review 2020;15:e63.

Overview:Management goals in patients with stable coronary disease or chronic coronary syndrome include controlling symptoms and reducing the risk of future... more

The Coronavirus Disease 2019 Outbreak Highlights the Importance of Sex-sensitive Medicine

Author : Angela Maas, Sabine Oertelt-Prigione

Citation :

European Cardiology Review 2020;15:e62.

Overview:While 2020 is only halfway through, we have already experienced a historical year in global healthcare with a high societal impact. When the first... more

The Impact of Ethnicity on Cardiac Adaptation

Author : Uchenna Ozo, Sanjay Sharma

Citation :

European Cardiology Review 2020;15:e61.

Overview:Athletes may occasionally succumb to sudden cardiac arrest because of a quiescent cardiac abnormality. These catastrophes are rare, affecting between 1... more

The Role of Nocturnal Blood Pressure and Sleep Quality in Hypertension Management

Author : Francesco P Cappuccio

Citation :

European Cardiology Review 2020;15:e60.

Overview:Hypertension is a major independent risk factor for cardiovascular (CV) diseases, including cardiac death, coronary heart disease, heart failure,... more

Treatment of Coronavirus Disease 2019: Shooting in the Dark

Author : Juan Tamargo

Citation :

European Cardiology Review 2020;15:e59.

Overview:“When the cause of the sickness is unknown, only a miracle can cure it.” Don Quixote... more

Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness

Author : Maki Komiyama, Koji Hasegawa

Citation :

European Cardiology Review 2020;15:e58.

Overview:Coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has generated a pandemic that... more

Coronavirus Disease 2019 and Catheterisation Laboratory Considerations: “Looking for Essentials”

Author : Syed Haseeb Raza Naqvi, Madiha Fatima, Fady Gerges, Sara Moscatelli, Tugba Kemaloglu Oz, Irina Kotlar, Nigar Babazade, Arash Hashemi, Abdallah Almaghraby

Citation :

European Cardiology Review 2020;15:e57.

Overview:The current coronavirus disease 2019 (COVID-19) outbreak is more than a health crisis, and its impact on the management of other diseases of various... more

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science

Author : Charles Amir German, Michael D Shapiro

Citation :

European Cardiology Review 2020;15:e56.

Overview:Cardiovascular disease (CVD) is the leading cause of mortality in the world, accounting for 17.9 million deaths per year and 31% of deaths worldwide.... more

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019

Author : Maki Komiyama, Koji Hasegawa

Citation :

European Cardiology Review 2020;15:e55.

Overview:Thank you very much for your interesting and important comments on our review that discussed smoking cessation to limit the coronavirus disease 2019 (... more

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019

Author : Marco Rossato, Angelo Di Vincenzo

Citation :

European Cardiology Review 2020;15:e54.

Overview:We read with interest the paper by Komiyama and Hasegawa on the need for smoking cessation as a public health measure to limit the coronavirus disease... more